John Erbey is a distinguished leader in the medical industry, serving as the CEO of Roivios and President of 3ive Labs. With over 25 years of experience, John has been instrumental in pioneering innovative solutions that significantly enhance patient care. His strategic leadership at Roivios has led to the development of the JuxtaFlow® Renal Assist Device (RAD), a groundbreaking invention that redefines kidney health management by preserving kidney function and expediting recovery.John's career is marked by a series of successful initiatives, including the launch of CardioMEMS, which highlights his ability to transform scientific advancements into practical healthcare solutions. His commitment to advancing kidney health is unwavering, as he leads Roivios towards a transformative U.S. launch in 2025, aiming to elevate patient quality of life and redefine kidney disease management.With a profound understanding of therapeutic development and medical devices, John is dedicated to fostering innovation and strategic partnerships. Engage with John to explore opportunities for collaboration and gain insights into the future of medical innovation, as Roivios continues to lead the way in revolutionizing kidney health.